InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: turks post# 11928

Thursday, 06/08/2017 1:37:48 PM

Thursday, June 08, 2017 1:37:48 PM

Post# of 16911
the treatment centers are gearing up .. this will bear fruit for MAT in the long term... this term there were challenges w/insurance, pharmacy access, etc that made it difficult for a smooth roll out to small proprietors (TTNP's & Braeburn's initial strategy)... remember Clean Slate is one such small proprietor (1 MD) who had the vision to assemble scale in MA.. the rest of the facilities are still being rolled out, no doubt w/Apple Tree funding (I am encouraged by their model & scale)... injectables & implantables are not a quick answer alone to treating opioid addiction... successful treatment is complex... for example some people on methadone maintenance also take opiods on top of their allotted methadone (sometimes called "chipping", for a variety of reasons)... difficult to detect in standard field urinalysis.. no chemistry grad student knows more about how to mask a dirty UA test than a determined addict... ultimately the metric is going to be how effective is any combination of interventions in maintaining a patient's ability to function: get & keep a job & successfully provide for food clothing shelter... bottom line, Braeburn's S1 revealed many challenges to marketing Probuphine & given TTNP's weak management record, investors sold.. I'm hoping for a buy out or for the TTNP Board to wake up & press management to perform or fire management... that's their job..oh that's right they're not doing their job either .. well that answers that... Braeburn needs success (revenue) to IPO.. that's the hope for TTNP shareholders; that Braeburn will do whatever they can to make that happen
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News